Modern Chinese Medicine Group Co Lt

Price Chart

Risk-Adjusted Performance

Modern Chinese Medicine Group Co Lt (1643) Price Performance

Modern Chinese Medicine Group Co Lt (1643) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at HKD1.99, up 25.16% from the previous close.

Over the past year, 1643 has traded between a low of HKD0.24 and a high of HKD1.99. The stock has gained 379.5% over this period. It is currently 712.2% above its 52-week low.

Modern Chinese Medicine Group Co Lt has a market capitalization of $957.60M, with a price-to-earnings ratio of 33.25.

About Modern Chinese Medicine Group Co Lt

Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China. It provides vigour and vitality supplement, circulation enhancement pills, cardiotonic enhancement capsules, heart wellness capsules, menstrual discomfort relief, liver detox tablets, liver-dispersing and stomach regulating pills, fever- removing and detoxification pills, kidney invigoration pills, and huoxiang zheng qi pills. The company offers its products as therapeutics for the treatment of qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and for symptoms of COVID-19 and similar illnesses. It also provides business support, technical, and consulting services. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.